메뉴 건너뛰기




Volumn 29, Issue 2, 2013, Pages 165-173

Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses;Stratégies génétiques, immunologiques et pharmacologiques au service d'une nouvelle génération de virus anticancéreux

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

EID: 84874738889     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013292014     Document Type: Article
Times cited : (5)

References (43)
  • 1
    • 0001511115 scopus 로고
    • The influence of complicating diseases upon leukemia
    • Dock G. The influence of complicating diseases upon leukemia. Am J Med Sci 1904; 127 : 563-92.
    • (1904) Am J Med Sci , vol.127 , pp. 563-592
    • Dock, G.1
  • 2
    • 33947245441 scopus 로고    scopus 로고
    • History of oncolytic viruses: Genesis to genetic engineering
    • Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Mol Ther; 15 : 651-9.
    • Mol Ther , vol.15 , pp. 651-659
    • Kelly, E.1    Russell, S.J.2
  • 3
    • 59849122602 scopus 로고    scopus 로고
    • Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers
    • Sinkovics JG, Horvath JC. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Arch Immunol Ther Exp 2008; 56 Suppl 1 : 3s-59s.
    • (2008) Arch Immunol Ther Exp , vol.56 , Issue.SUPPL. 1
    • Sinkovics, J.G.1    Horvath, J.C.2
  • 4
    • 0016358317 scopus 로고
    • Treatment of human cancer with mumps virus
    • Asada T. Treatment of human cancer with mumps virus. Cancer 1974; 34 : 1907-28.
    • (1974) Cancer , vol.34 , pp. 1907-1928
    • Asada, T.1
  • 5
    • 34548062828 scopus 로고    scopus 로고
    • Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow
    • Breitbach CJ, Paterson JM, Lemay CG, et al. Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. Mol Ther 2007; 15 : 1686-93.
    • (2007) Mol Ther , vol.15 , pp. 1686-1693
    • Breitbach, C.J.1    Paterson, J.M.2    Lemay, C.G.3
  • 6
    • 38649123395 scopus 로고    scopus 로고
    • Innate immunity, tumor microenvironment and oncolytic virus therapy: Friends or foes?
    • Stanford MM, Breitbach CJ, Bell JC, McFadden G. Innate immunity, tumor microenvironment and oncolytic virus therapy: friends or foes? Curr Opin Mol Ther 2008; 10 : 32-7.
    • (2008) Curr Opin Mol Ther , vol.10 , pp. 32-37
    • Stanford, M.M.1    Breitbach, C.J.2    Bell, J.C.3    McFadden, G.4
  • 7
    • 33847319116 scopus 로고    scopus 로고
    • Cancer selective adenoviruses
    • Alemany R. Cancer selective adenoviruses. Mol Aspects Med 2007; 28 : 42-58.
    • (2007) Mol Aspects Med , vol.28 , pp. 42-58
    • Alemany, R.1
  • 8
    • 0033929057 scopus 로고    scopus 로고
    • Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
    • Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 2000; 6 : 821-5.
    • (2000) Nat Med , vol.6 , pp. 821-825
    • Stojdl, D.F.1    Lichty, B.2    Knowles, S.3
  • 9
    • 10744223476 scopus 로고    scopus 로고
    • VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
    • Stojdl DF, Lichty BD, tenOever BR, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003; 4 : 263-75.
    • (2003) Cancer Cell , vol.4 , pp. 263-275
    • Stojdl, D.F.1    Lichty, B.D.2    Tenoever, B.R.3
  • 10
    • 0027971239 scopus 로고
    • In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy
    • Whitman ED, Tsung K, Paxson J, Norton JA. In vitro and in vivo kinetics of recombinant vaccinia virus cancer-gene therapy. Surgery 1994; 116 : 183-8.
    • (1994) Surgery , vol.116 , pp. 183-188
    • Whitman, E.D.1    Tsung, K.2    Paxson, J.3    Norton, J.A.4
  • 11
    • 0033565215 scopus 로고    scopus 로고
    • Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice
    • Gnant MF, Puhlmann M, Alexander HR, Jr., Bartlett DL. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice. Cancer Res 1999; 59 : 3396-403.
    • (1999) Cancer Res , vol.59 , pp. 3396-3403
    • Gnant, M.F.1    Puhlmann, M.2    Alexander Jr., H.R.3    Bartlett, D.L.4
  • 12
    • 77955177289 scopus 로고    scopus 로고
    • Identification of genetically modified Maraba virus as an oncolytic rhabdovirus
    • Brun J, McManus D, Lefebvre C, et al. Identification of genetically modified Maraba virus as an oncolytic rhabdovirus. Mol Ther 2010; 18 : 40-9.
    • (2010) Mol Ther , vol.18 , pp. 40-49
    • Brun, J.1    McManus, D.2    Lefebvre, C.3
  • 13
    • 36049009021 scopus 로고    scopus 로고
    • Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
    • Thorne SH, Hwang TH, O'Gorman WE, et al. Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J Clin Invest 2007; 117 : 3350-8.
    • (2007) J Clin Invest , vol.117 , pp. 3350-3358
    • Thorne, S.H.1    Hwang, T.H.2    O'Gorman, W.E.3
  • 14
    • 84863722111 scopus 로고    scopus 로고
    • Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferonbeta
    • Naik S, Nace R, Barber GN, Russell SJ. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferonbeta. Cancer Gene Ther 2012; 19 : 443-50.
    • (2012) Cancer Gene Ther , vol.19 , pp. 443-450
    • Naik, S.1    Nace, R.2    Barber, G.N.3    Russell, S.J.4
  • 15
    • 63949087329 scopus 로고    scopus 로고
    • Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses
    • Zamarin D, Martinez-Sobrido L, Kelly K, et al. Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. Mol Ther 2009; 17 : 697-706.
    • (2009) Mol Ther , vol.17 , pp. 697-706
    • Zamarin, D.1    Martinez-Sobrido, L.2    Kelly, K.3
  • 16
    • 42049121876 scopus 로고    scopus 로고
    • Enhancing poxvirus oncolytic effects through increased spread and immune evasion
    • Kirn DH, Wang Y, Liang W, et al. Enhancing poxvirus oncolytic effects through increased spread and immune evasion. Cancer Res 2008; 68 : 2071-5.
    • (2008) Cancer Res , vol.68 , pp. 2071-2075
    • Kirn, D.H.1    Wang, Y.2    Liang, W.3
  • 17
    • 66849141991 scopus 로고    scopus 로고
    • Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: In vitro and in vivo evaluation
    • Jin J, Liu H, Yang C, et al. Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation. Mol Cancer Ther 2009; 8 : 1387-97.
    • (2009) Mol Cancer Ther , vol.8 , pp. 1387-1397
    • Jin, J.1    Liu, H.2    Yang, C.3
  • 18
    • 36348950417 scopus 로고    scopus 로고
    • Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine
    • Ungerechts G, Springfeld C, Frenzke ME, et al. Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. Cancer Res 2007; 67 : 10939-47.
    • (2007) Cancer Res , vol.67 , pp. 10939-10947
    • Ungerechts, G.1    Springfeld, C.2    Frenzke, M.E.3
  • 19
    • 1442356959 scopus 로고    scopus 로고
    • Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
    • Dingli D, Peng KW, Harvey ME, et al. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood 2004; 103 : 1641-6.
    • (2004) Blood , vol.103 , pp. 1641-1646
    • Dingli, D.1    Peng, K.W.2    Harvey, M.E.3
  • 20
    • 77953137806 scopus 로고    scopus 로고
    • Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers
    • Liu C, Russell SJ, Peng KW. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers. Mol Ther 2010; 18 : 1155-64.
    • (2010) Mol Ther , vol.18 , pp. 1155-1164
    • Liu, C.1    Russell, S.J.2    Peng, K.W.3
  • 22
    • 74549226667 scopus 로고    scopus 로고
    • Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
    • Lee JH, Roh MS, Lee YK, et al. Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model. Cancer Gene Ther 2009; 17 : 73-9.
    • (2009) Cancer Gene Ther , vol.17 , pp. 73-79
    • Lee, J.H.1    Roh, M.S.2    Lee, Y.K.3
  • 23
    • 57649125119 scopus 로고    scopus 로고
    • An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors
    • Lei N, Shen FB, Chang JH, et al. An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors. Cancer Gene Ther 2009; 16 : 33-43.
    • (2009) Cancer Gene Ther , vol.16 , pp. 33-43
    • Lei, N.1    Shen, F.B.2    Chang, J.H.3
  • 24
    • 73449144100 scopus 로고    scopus 로고
    • Buy one get one free: Armed viruses for the treatment of cancer cells and their microenvironment
    • Kaur B, Cripe TP, Chiocca EA. "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment. Curr Gene Ther 2009; 9 : 341-55.
    • (2009) Curr Gene Ther , vol.9 , pp. 341-355
    • Kaur, B.1    Cripe, T.P.2    Chiocca, E.A.3
  • 25
    • 0037345805 scopus 로고    scopus 로고
    • Neoadjuvant treatment of hepatic malignancy: An oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection
    • Jarnagin WR, Zager JS, Klimstra D, et al. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection. Cancer Gene Ther 2003; 10 : 215-23.
    • (2003) Cancer Gene Ther , vol.10 , pp. 215-223
    • Jarnagin, W.R.1    Zager, J.S.2    Klimstra, D.3
  • 26
    • 1642535483 scopus 로고    scopus 로고
    • Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12
    • Wong RJ, Chan MK, Yu Z, et al. Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12. Clin Cancer Res 2004; 10 : 251-9.
    • (2004) Clin Cancer Res , vol.10 , pp. 251-259
    • Wong, R.J.1    Chan, M.K.2    Yu, Z.3
  • 27
    • 32844475008 scopus 로고    scopus 로고
    • Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers
    • Varghese S, Rabkin SD, Liu R, et al. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers. Cancer Gene Ther 2006; 13 : 253-65.
    • (2006) Cancer Gene Ther , vol.13 , pp. 253-265
    • Varghese, S.1    Rabkin, S.D.2    Liu, R.3
  • 28
    • 0034050884 scopus 로고    scopus 로고
    • Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
    • Parker JN, Gillespie GY, Love CE, et al. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci USA 2000; 97 : 2208-13.
    • (2000) Proc Natl Acad Sci USA , vol.97 , pp. 2208-2213
    • Parker, J.N.1    Gillespie, G.Y.2    Love, C.E.3
  • 29
    • 76349109690 scopus 로고    scopus 로고
    • Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
    • Huang JH, Zhang SN, Choi KJ, et al. Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL. Mol Ther 2010; 18 : 264-74.
    • (2010) Mol Ther , vol.18 , pp. 264-274
    • Huang, J.H.1    Zhang, S.N.2    Choi, K.J.3
  • 30
    • 28244502278 scopus 로고    scopus 로고
    • Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system
    • Fukuhara H, Ino Y, Kuroda T, et al. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system. Cancer Res 2005; 65 : 10663-8.
    • (2005) Cancer Res , vol.65 , pp. 10663-10668
    • Fukuhara, H.1    Ino, Y.2    Kuroda, T.3
  • 31
    • 84855968515 scopus 로고    scopus 로고
    • Potentiating cancer immunotherapy using an oncolytic virus
    • Bridle BW, Stephenson KB, Boudreau JE, et al. Potentiating cancer immunotherapy using an oncolytic virus. Mol Ther 2010; 184 : 4269-75.
    • (2010) Mol Ther , vol.184 , pp. 4269-4275
    • Bridle, B.W.1    Stephenson, K.B.2    Boudreau, J.E.3
  • 32
    • 77953479211 scopus 로고    scopus 로고
    • Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer
    • Castelo-Branco P, Passer BJ, Buhrman JS, et al. Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer. Gene Ther 2010; 17 : 805-10.
    • (2010) Gene Ther , vol.17 , pp. 805-810
    • Castelo-Branco, P.1    Passer, B.J.2    Buhrman, J.S.3
  • 33
    • 76349112703 scopus 로고    scopus 로고
    • Intelligent design: Combination therapy with oncolytic viruses
    • Ottolino-Perry K, Diallo JS, Lichty BD, et al. Intelligent design: combination therapy with oncolytic viruses. Mol Ther 2010; 18 : 251-63.
    • (2010) Mol Ther , vol.18 , pp. 251-263
    • Ottolino-Perry, K.1    Diallo, J.S.2    Lichty, B.D.3
  • 34
    • 77951987824 scopus 로고    scopus 로고
    • Synergistic interaction between oncolytic viruses augments tumor killing
    • Le Boeuf F, Diallo JS, McCart JA, et al. Synergistic interaction between oncolytic viruses augments tumor killing. Mol Ther 2010; 18 : 888-95.
    • (2010) Mol Ther , vol.18 , pp. 888-895
    • Le Boeuf, F.1    Diallo, J.S.2    McCart, J.A.3
  • 35
    • 77953544825 scopus 로고    scopus 로고
    • Oncolytic viruses and histone deacetylase inhibitors-A multi-pronged strategy to target tumor cells
    • Nguyen TL, Wilson MG, Hiscott J. Oncolytic viruses and histone deacetylase inhibitors-a multi-pronged strategy to target tumor cells. Cytokine Growth Factor Rev 2010; 21 : 153-9.
    • (2010) Cytokine Growth Factor Rev , vol.21 , pp. 153-159
    • Nguyen, T.L.1    Wilson, M.G.2    Hiscott, J.3
  • 36
    • 0032814773 scopus 로고    scopus 로고
    • Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
    • Ikeda K, Ichikawa T, Wakimoto H, et al. Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med 1999; 5 : 881-7.
    • (1999) Nat Med , vol.5 , pp. 881-887
    • Ikeda, K.1    Ichikawa, T.2    Wakimoto, H.3
  • 37
    • 77953135826 scopus 로고    scopus 로고
    • A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers
    • Diallo JS, Le Boeuf F, Lai F, et al. A high-throughput pharmacoviral approach identifies novel oncolytic virus sensitizers. Mol Ther 2010; 18 : 1123-9.
    • (2010) Mol Ther , vol.18 , pp. 1123-1129
    • Diallo, J.S.1    Le Boeuf, F.2    Lai, F.3
  • 38
    • 77952869168 scopus 로고    scopus 로고
    • Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication
    • Passer BJ, Cheema T, Zhou B, et al. Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication. Cancer Res 2010; 70 : 3890-5.
    • (2010) Cancer Res , vol.70 , pp. 3890-3895
    • Passer, B.J.1    Cheema, T.2    Zhou, B.3
  • 40
    • 80052406557 scopus 로고    scopus 로고
    • Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans
    • Breitbach CJ, Burke J, Jonker D, et al. Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans. Nature 2011; 477 : 99-102.
    • (2011) Nature , vol.477 , pp. 99-102
    • Breitbach, C.J.1    Burke, J.2    Jonker, D.3
  • 41
    • 84860870216 scopus 로고    scopus 로고
    • Le virus de la rougeole - Un futur traitement en cancérologie ?
    • Touchefeu Y, Schick U, Harrington KJ. Le virus de la rougeole - Un futur traitement en cancérologie ? Med Sci (Paris) 2012; 28 : 388-94.
    • (2012) Med Sci (Paris) , vol.28 , pp. 388-394
    • Touchefeu, Y.1    Schick, U.2    Harrington, K.J.3
  • 42
    • 84860868454 scopus 로고    scopus 로고
    • Apprivoiser nos ennemis pour en faire des alliés : la « virothérapie » anticancéreuse
    • Lemay G. Apprivoiser nos ennemis pour en faire des alliés : la « virothérapie » anticancéreuse. Med Sci (Paris) 2012; 28 : 339-40.
    • (2012) Med Sci (Paris) , vol.28 , pp. 339-340
    • Lemay, G.1
  • 43
    • 84874712759 scopus 로고    scopus 로고
    • Le virus de la stomatite vésiculaire dans la lutte contre le cancer
    • Janelle V, Poliquin L, Lamarre A. Le virus de la stomatite vésiculaire dans la lutte contre le cancer. Med Sci (Paris) 2013, 29 : 175-82.
    • (2013) Med Sci (Paris) , vol.29 , pp. 175-182
    • Janelle, V.1    Poliquin, L.2    Lamarre, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.